Atopic Dermatitis, also known as atopic eczema, or eczema, is a common skin disease that can
affect males and females of all ages, but often starts in childhood. Recent studies show at
least 4-7% of adults and 15-25% of children to be affected, with one third of patients having
severe disease. It results in very itchy, red, swollen, and cracked skin. Scratching worsens
the symptoms and causes the skin to become thickened over time. Patients with atopic
dermatitis have an increased risk of skin infections, and many also develop hay fever or
asthma. Atopic dermatitis can cause significant distress to both patients and their families.
In this study, the aim is to assess the effects of a new treatment called secukinumab in
patients with atopic dermatitis. A total of 30 patients will be included in the study, which
will run for a total of 52 weeks.